Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.32 |
| ▸ | MAP3K12 | Q12852 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.30 |
| ▸ | ASPH | Q12797 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9276814 | 0.98 | MBOAT4 (0.36) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL29435785 | 0.98 | MBOAT4 (0.36) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL13973112 | 0.83 | HPGD (0.36) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL31214202 | 0.83 | HPGD (0.36) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL15862849 | 0.82 | NOS3 (0.32) | NOS3NOS2NOS1 | |
| SCHEMBL29936876 | 0.80 | HPGD (0.34) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL31240982 | 0.78 | LMNA (0.38) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL21606876 | 0.78 | PIK3CD (0.36) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| Hydrochloric Acid SCHEMBL27573305 | 0.77 | PIK3CD (0.35) | MBOAT4HPGDHSD17B10NOS3NOS2 | |
| SCHEMBL28490357 | 0.75 | MBOAT4 (0.37) | MBOAT4HPGDHSD17B10AURKAKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278983-B2 | Fused heterocyclic compound and use thereof for pest control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-03-08 | — | — | US | disclosed |
| US-20140364444-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364444-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL | NR4A1, NR2C2, NR0B1 | MBOAT4 3664/4885HPGD 4230/4885HSD17B10 1343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.